K. Youkhana Et Al. , "Assessing cancer risk in patients with HFE gene variants and type 1 hereditary hemochromatosis," 42nd European-Society-for-Medical-Oncology Congress (ESMO) , vol.28, Madrid, Spain, 2017
Youkhana, K. Et Al. 2017. Assessing cancer risk in patients with HFE gene variants and type 1 hereditary hemochromatosis. 42nd European-Society-for-Medical-Oncology Congress (ESMO) , (Madrid, Spain).
Youkhana, K., Tutaeva, V., Williams, H., Corbali, O., Krishnamurthy, S., Metpally, R., ... Kip, N.(2017). Assessing cancer risk in patients with HFE gene variants and type 1 hereditary hemochromatosis . 42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid, Spain
Youkhana, K. Et Al. "Assessing cancer risk in patients with HFE gene variants and type 1 hereditary hemochromatosis," 42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid, Spain, 2017
Youkhana, K. Et Al. "Assessing cancer risk in patients with HFE gene variants and type 1 hereditary hemochromatosis." 42nd European-Society-for-Medical-Oncology Congress (ESMO) , Madrid, Spain, 2017
Youkhana, K. Et Al. (2017) . "Assessing cancer risk in patients with HFE gene variants and type 1 hereditary hemochromatosis." 42nd European-Society-for-Medical-Oncology Congress (ESMO) , Madrid, Spain.
@conferencepaper{conferencepaper, author={K. Youkhana Et Al. }, title={Assessing cancer risk in patients with HFE gene variants and type 1 hereditary hemochromatosis}, congress name={42nd European-Society-for-Medical-Oncology Congress (ESMO)}, city={Madrid}, country={Spain}, year={2017}}